Provided by Tiger Fintech (Singapore) Pte. Ltd.

AIM ImmunoTech Inc.

9.50
+0.29003.15%
Post-market: 9.500.00000.00%16:27 EDT
Volume:12.20K
Turnover:120.26K
Market Cap:7.26M
PE:-0.38
High:10.38
Open:9.59
Low:9.50
Close:9.21
Loading ...
Apr 27, 2020

Major Issues Report

8-K - Current report
Apr 16, 2020

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Apr 06, 2020

Major Issues Report

Current report, items 1.01, 7.01, and 9.01
Mar 30, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2020

Major Issues Report

Current report, items 1.01, 7.01, and 9.01
Mar 26, 2020

Major Issues Report

8-K - Current report
Mar 09, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 18, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Jan 31, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Dec 11, 2019

Major Issues Report

Current report, items 1.01, 2.03, and 9.01
Dec 04, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Nov 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 17, 2019

Major Issues Report

Current report, item 5.02
Oct 07, 2019

Major Issues Report

Current report, items 2.02, 5.07, 8.01, and 9.01
Sep 30, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Sep 27, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Sep 25, 2019

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Sep 24, 2019

Correspondence

[Cover]Correspondence